Disease control implications of India's changing multi-drug resistant tuberculosis epidemic

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Suen, Sze Chuan ^a   Bendavid, Eran ^b,c   Goldhaber Fiebert, Jeremy D ^c  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL TRANSMISSION; EPIDEMIC; EPIDEMIOLOGICAL DATA; INCIDENCE; INDIA; LATENT TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; PREVALENCE; SHORT COURSE THERAPY; SIMULATION; TUBERCULOSIS CONTROL; ADOLESCENT; ADULT; AGED; CHILD; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; PRESCHOOL CHILD; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84897553536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089822     Document Type: Article

References (42)

1. World Health Organization (2011) Global tuberculosis control 2011. Geneva, Switzerland.
2. World Health Organization (2011) India: Multidrug-resistant tuberculosis profile. Geneva, Switzerland. Available: www.who.int/tb/data.
3. Crofton J, Chaulet P, Maher D (1997) Guidelines for the management of drug-resistant tuberculosis. World Health Organization 210.
4. Heym B, Honoré N, Truffot-Pernot C, Banerjee A, Schurra C, et al. (1994) Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 344: 293-298. (Pubitemid 24230296)
5. World Health Organization News Release (2010) Drug-resistant tuberculosis now at record levels. Geneva, Switzerland.
6. Andrews JR, Gandhi NR, Moodley P, Shah NS, Bohlken L, et al. (2008) Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa. J Infect Dis 198: 1582-1589. doi:10.1086/592991.
7. Zhao Y, Xu S, Wang L, Chin DP, Wang S, et al. (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med 366: 2161-2170. doi:10.1056/NEJMoa1108789.
8. Tobgay KJ, Sarma PS, Thankappan K (2006) Predictors of treatment delays for tuberculosis in Sikkim. Natl Med J India 19
9. Central TB Division Directorate General of Health Services and Ministry of Health and Family Welfare (2011) TB India 2011 RNTCP Annual Status Report.
10. Udwadia ZF, Pinto LM, Uplekar MW (2010) Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? PloS one 5: e12023. doi:10.1371/journal.pone.0012023.
11. Vandan N, Ali M, Prasad R, Kuroiwa C (2009) Assessment of doctors' knowledge regarding tuberculosis management in Lucknow, India: a public-private sector comparison. Public Health 123: 484-489. doi:10.1016/j.puhe.2009.05.004.
12. Uplekar MW, Shepard DS (1991) Treatment of tuberculosis by private general practitioners in India. Tubercle 72: 284-290.
13. Rajeswari R, Chandrasekaran V, Suhadev M, Sivasubramaniam S, Sudha G, et al. (2002) Factors associated with patient and health system delays in the diagnosis of tuberculosis in South India. Int J Tuberc Lung Dis 6: 789-795. Available: http://www.ncbi.nlm.nih.gov/pubmed/12234134. (Pubitemid 34988049)
14. Dye C (2012) The potential impact of new diagnostic tests on tuberculosis epidemics. Indian J Med Res 135: 737-744.
15. Rowland K (2012) Totally drug-resistant TB emerges in India. Nature News. doi:10.1038/nature.2012.9797.
16. Government of India National DOTS-Plus Committee (2011) Minutes of the Seventh National DOTS-Plus Committee Meeting LRS Institute, New Delhi, 11th and 12th July 2011. Minutes of the Seventh National DOTS-Plus Committee Meeting LRS Institute, New Delhi, 11th and 12th July 2011. Vol. 756. pp. 1-33. Available: http://www.tbcindia.nic.in/pdfs/ FinalMinutesof7thNationalDOTSPlusCommitteeMeeting-11-120711.pdf.
17. Goldhaber-Fiebert JD, Stout NK, Goldie SJ (2010) Empirically evaluating decision-analytic models. Value In Health: The Journal Of The International Society For Pharmacoeconomics And Outcomes Research 13: 667-674. Available: http://www.ncbi.nlm.nih.gov/pubmed/20230547
18. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat (2010) World Population Prospects: The 2010 Revision. Available: http://esa.un.org/unpd/wpp/index.htm.
19. Rosenzweig MR (1994) Intergenerational family relations in rural India. Ageing Int 21: 50-57.
20. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5: e74. doi:10.1371/journal.pmed.0050074. (Pubitemid 351471689)
21. Keeling M, Rohani P (2007) Modeling infectious diseases in humans and animals. 1st ed. Princeton University Press.
22. Horby P, Pham QT, Hens N, Nguyen TTY, Le QM, et al. (2011) Social contact patterns in Vietnam and implications for the control of infectious diseases. PloS One 6: e16965. doi:10.1371/journal.pone.0016965.
23. Horsburgh CR (2004) Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 350: 2060-2067. doi:10.1056/NEJMsa031667. (Pubitemid 38596557)
24. Vynnycky E, Fine PE (1997) The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 119: 183-201. (Pubitemid 27474799)
25. Balasubramanian R, Garg R, Santha T, Gopi PG, Subramani R, et al. (2004) Gender disparities in tuberculosis: report from a rural dots programme in south India. Int J Tuberc Lung Dis 8: 323-332. Available: http://www.ncbi.nlm.nih. gov/pubmed/15139471. (Pubitemid 38624869)
26. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, et al. (2002) Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur district, south India, 2000. Int J Tuberc Lung Dis 6: 780-788. Available: http://www.ncbi.nlm. nih.gov/pubmed/12234133 (Pubitemid 34988048)
27. Central TB Division Directorate General of Health Services and Ministry of Health and Family Welfare (2010) RNTCP performance report, India: Third quarter, 2010. Available: http://www.tbcindia.org.
28. Srikanth P, Kamesh S, Daley P (2009) Bleach optimization of sputum smear microscopy for pulmonary tuberculosis. Indian J Tuberc 56: 174-184.
29. Chang K, Lu W, Wang J, Zhang K, Jia S, et al. (2012) Rapid and effective diagnosis of tuberculosis and rifampicin resistance with XPERT MTB/RIF assay: a meta-analysis. J Infect 64: 580-588. doi:10.1016/j.jinf.2012.02.012.
30. Singla R, Sarin R, Khalid UK, Mathuria K, Singla N, et al. (2009) Seven-year DOTS-Plus pilot experience in India: results, constraints and issues. Int J Tuberc Lung Dis 13: 976-981.
31. Kapoor SK, Raman a V, Sachdeva KS, Satyanarayana S (2012) How did the TB patients reach DOTS services in Delhi? A study of patient treatment seeking behavior. PloS One 7: e42458. doi:10.1371/journal.pone.0042458.
32. Pantoja A, Floyd K, Unnikrishnan KP, Jitendra R, Padma MR, et al. (2009) Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients. Int J Tuberc Lung Dis 13: 698-704.
33. Malmborg R, Mann G, Thomson R, Squire SB (2006) Can public-private collaboration promote tuberculosis case detection among the poor and vulnerable? Bulletin of the World Health Organization 84: 752-758. (Pubitemid 44482402)
34. World Health Organization (2010) WHO Lifetables for India. Geneva, Switzerland. Available: http://apps.who.int/ghodata/?vid=720.
35. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA, J Am Med Assoc 282: 677-686. (Pubitemid 29384157)
36. World Health Organization (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland.
37. COHESIVE-India Bihar Evaluation of Social Franchising and Telemedicine (2011) Available: www.cohesiveindia.org. Accessed 2013 June 4.
38. Cohen T, Murray M (2004) Modeling epidemics of multidrug-resistant M. Tuberculosis of heterogeneous fitness. Nature Medicine 10: 1117-1121. doi:10.1038/nm1110.Modeling. (Pubitemid 39424874)
39. Sinha K (2012) Now, 2-hr Test to Detect Drug-Resistant TB. The Times of India: 18-20. Available: http://articles.timesofindia.indiatimes.com/2012-02-01/ india/31012478-1-mdr-tb-tb-cases-single-drug-resistant-case.
40. Satyanarayana S, Nair SA, Chadha SS, Shivashankar R, Sharma G, et al. (2011) From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PloS One 6: e24160. doi:10.1371/journal.pone.0024160.
41. Sharma SK, Kaushik G, Jha B, George N, Arora SK, et al. (2011) Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian J Med Res 133: 308-311.
42. Sachdeva KS (2011) Overview of drug resistant TB in India and national scale up of MDR TB diagnosis and treatment TB burden in India. Facing the Reality Of Multidrug-Resistant Tuberculosis: Challenges and Potential Solutions in India, Apr 18-19. New Delhi, India: Indian National Science Academy.